On page 462 of this article, the group of Chris Marshall should have been credited, alongside those of Jasper Rine and Sang–Ho Kim, with the discovery of RAS isoprenylation. The text and references should have been:
In two landmark papers published in 1989 (REFS 85,86), the groups of Chris Marshall and of Jasper Rine, the latter in collaboration with Sang–Ho Kim, described isoprenylation as a novel mechanism of post-translational modification of proteins, which allowed them to identify the biochemical basis for the attachment of RAS proteins to membranes.
85. Hancock, J. F., Magee, A. I., Childs, J. E. & Marshall, C. J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57, 1167–1177 (1989).
86. Schafer, W. R. et al. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science 245, 379–385 (1989).
Additional information
The online version of the original article can be found at 10.1038/nrc1097
Rights and permissions
About this article
Cite this article
Malumbres, M., Barbacid, M. Correction: RAS oncogenes: The first 30 years. Nat Rev Cancer 3, 708 (2003). https://doi.org/10.1038/nrc1193
Issue Date:
DOI: https://doi.org/10.1038/nrc1193
This article is cited by
-
RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data
Current Treatment Options in Oncology (2015)
-
K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function
Oncogene (2010)
